发明名称 LIPOCATIONIC DENDRIMERS AND USES THEREOF
摘要 Modular dendrimers with cationic groups and lipophilic groups are provided herein. In some aspects, the dendrimers provided herein may be formulated in compositions which contain a nucleic acid and one or more helper excipients. In some aspects, these compositions may also be used to treat diseases or disorders with a therapeutic nucleic acid.
申请公布号 US2017121279(A1) 申请公布日期 2017.05.04
申请号 US201615265064 申请日期 2016.09.14
申请人 The Board of Regents of the University of Texas System 发明人 SIEGWART Daniel J.;ZHOU Kejin
分类号 C07C321/14;A61K31/7125;A61K47/20;C07D295/15;A61K47/22 主分类号 C07C321/14
代理机构 代理人
主权项 1. A dendrimer of the formula: Core-(Repeating Unit)n-Terminating Group  (I) wherein the core is linked to the repeating unit by removing one or more hydrogen atoms from the core and replacing the atom with the repeating unit and wherein: the core has the formula: wherein: X1 is amino or alkylamino(C≦12), dialkylamino(C≦12), heterocycloalkyl(C≦12), heteroaryl(C≦12), or a substituted version thereof;R1 is amino, hydroxy, or mercapto, or alkylamino(C≦12), dialkylamino(C≦12), or a substituted version of either of these groups; anda is 1, 2, 3, 4, 5, or 6; orthe core has the formula: wherein: X2 is N(R5)y; R5 is hydrogen, alkyl(C≦18), or substituted alkyl(C≦18); andy is 0, 1, or 2, provided that the sum of y and z is 3;R2 is amino, hydroxy, or mercapto, or alkylamino(C≦12), dialkylamino(C≦12), or a substituted version of either of these groups;b is 1, 2, 3, 4, 5, or 6; andz is 1, 2, 3; provided that the sum of z and y is 3; orthe core has the formula: wherein: X3 is —NR6—, wherein R6 is hydrogen, alkyl(C≦8), or substituted alkyl(C≦8), —O—, or alkylaminodiyl(C≦8), alkoxydiyl(C≦8), arenediyl(C≦8), heteroarenediyl(C≦8), heterocycloalkanediyl(C≦8), or a substituted version of any of these groups;R3 and R4 are each independently amino, hydroxy, or mercapto, or alkylamino(C≦12), dialkylamino(C≦12), or a substituted version of either of these groups; or a group of the formula: —(CH2CH2N)e(Rc)Rd;wherein: e is 1, 2, or 3;Rc and Rd are each independently hydrogen, alkyl(C≦6), or substituted alkyl(C≦6);c and d are each independently 1, 2, 3, 4, 5, or 6; orthe core is alkylamine(C≦18), dialkylamine(C≦36), heterocycloalkane(C≦12), or a substituted version of any of these groups;wherein the repeating unit comprises a degradable diacyl and a linker; the degradable diacyl group has the formula: wherein: A1 and A2 are each independently —O— or —NRa—, wherein: Ra is hydrogen, alkyl(C≦6), or substituted alkyl(C≦6);Y3 is alkanediyl(C≦12), alkenediyl(C≦12), arenediyl(C≦12), or a substituted version of any of these groups; or a group of the formula: wherein: X3 and X4 are alkanediyl(C≦12), alkenediyl(C≦12), arenediyl(C≦12), or a substituted version of any of these groups; Y5 is a covalent bond, alkanediyl(C≦12), alkenediyl(C≦12), arenediyl(C≦12), or a substituted version of any of these groups; andR9 is alkyl(C≦8) or substituted alkyl(C≦8);the linker group has the formula: wherein: Y1 is alkanediyl(C≦12), alkenediyl(C≦12), arenediyl(C≦12), or a substituted version of any of these groups; andwherein when the repeating unit comprises a linker group, then the linker group is attached to a degradable diacyl group on both the nitrogen and the sulfur atoms of the linker group, wherein the first group in the repeating unit is a degradable diacyl group, wherein for each linker group, the next group comprises two degradable diacyl groups attached to the nitrogen atom of the linker group; and wherein n is the number of linker groups present in the repeating unit; andthe terminating group has the formula: wherein: Y4 is alkanediyl(C≦18) or an alkanediyl(C≦18) wherein one or more of the hydrogen atoms on the alkanediyl(C≦18) has been replaced with —OH, —F, —Cl, —Br, —I, —SH, —OCH3, —OCH2CH3, —SCH3, or —OC(O)CH3;R10 is hydrogen, carboxy, hydroxy, oraryl(C≦12), alkylamino(C≦12), dialkylamino(C≦12), N-heterocycloalkyl(C≦12), —C(O)N(R11)-alkanediyl(C≦6)-heterocycloalkyl(C≦12), —C(O)-alkyl-amino(C≦12), —C(O)-dialkylamino(C≦12), —C(O)—N-heterocyclo-alkyl(C≦12), wherein: R11 is hydrogen, alkyl(C≦6), or substituted alkyl(C≦6);wherein the final degradable diacyl in the chain is attached to a terminating group;n is 0, 1, 2, 3, 4, 5, or 6; or a pharmaceutically acceptable salt thereof.
地址 Austin TX US